WashU CAR-T for T-Cell Lymphoma Wins FDA Breakthrough Designation

An innovative CAR-T therapy targeting T-cell cancers — historically difficult because CAR-T cells attack each other — receives Breakthrough Therapy designation, opening a new frontier in cell therapy.